Skin disorders, Planning

Applied filters

Guidance (29)
- Safety in Breastfeeding (29)
- Stability in dosette boxes (11)
- Stability outside the fridge (7)
Medicine (71)
- Aciclovir (1)
- Adalimumab (1)
- Adapalene (1)
- Adapalene + Benzoyl peroxide (1)
- Alitretinoin (1)
- Aminolevulinic acid hydrochloride (1)
- Apremilast (1)
- Beclometasone (1)
- Brimonidine (1)
- Brodalumab (1)
- Calcipotriol (1)
- Calcipotriol + Betamethasone (1)
- Ciclosporin (1)
- Clobetasol (1)
- Clotrimazole (1)
- Dapsone (1)
- Dimethyl fumarate (1)
- Dupilumab (1)
- Eflornithine (1)
- Etanercept (1)
- Fluocinolone acetonide (1)
- Fluticasone (1)
- Glycopyrronium (1)
- Guselkumab (1)
- Hydrocortisone (1)
- Hydrogen peroxide (1)
- Imiquimod (1)
- Infliximab (1)
- Ingenol mebutate (1)
- Ivermectin (1)
- Ixekizumab (1)
- Miconazole (1)
- Mometasone (1)
- Nalbuphine (1)
- Oxymetazoline (1)
- Pimecrolimus (1)
- Retapamulin (1)
- Risankizumab (1)
- Rituximab (1)
- Ruxolitinib (1)
- Secukinumab (1)
- Sirolimus (1)
- Tacalcitol (1)
- Tacrolimus (1)
- Tazarotene (1)
- Terbinafine (1)
- Tildrakizumab (1)
- Tofacitinib (1)
- Trametinib (1)
- Triamcinolone acetonide (1)
- Ustekinumab (1)
Planning (91)
- Advanced therapy medicinal products (2)
- Biosimilars (4)
- New Medicines (75)
  - CCG commissioned new medicines (59)
  - NHS England commissioned new medicines (22)
  - Pre-registration new medicines (UK/EU) (11)
- Patent expiries (37)
Specialty (91)
- Allergy and immunology (8)
- Anaesthesia and pain (2)
- Cancers (8)
- Cardiovascular system disorders (1)
- Ear, nose and throat disorders (9)
- Endocrine system disorders (1)
- Eyes and vision (8)
- Gastrointestinal disorders (7)
- Infection and infectious diseases (7)
- Musculo-skeletal disorders (14)
- Neurological disorders (1)
- Respiratory disorders (7)
- Skin disorders (91)